Key facts
- Notable investors include CNT Tech, AI Angel Club, Dongguk University.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for L&P Solution
- ·The full record, as it builds
Funding rounds
No funding rounds for L&P Solution are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About L&P Solution
Developer of a computational drug discovery platform designed for early-stage pharmaceutical research. The company's platform combines molecular modeling, virtual screening, in-silico simulation, AI-driven compound design, toxicology prediction, and biologics modeling, enabling biotech firms, academic labs, and pharmaceutical companies to identify promising drug candidates more efficiently with reduced cost, lower failure rates, and faster iteration in early discovery phases.
- Sector
- Healthcare
- HQ
- Hongcheon-gun, South Korea
- Founded
- 2022
- Employees
- 4
- Website
- lnpsolution.com/
- Ownership
- Privately Held (backing)
L&P Solution doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in L&P Solution shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on L&P Solution in its N-PORT filings yet. We sweep new filings monthly.